Complete FDA and NHTSA recall records dated in 2019, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Undeclared milk. Buttermilk pancake mix which contains milk was packed in Best Choice Pancake & Waffle Complete Mix Original retail cartons which do not declare milk as an ingredient.
Firm received a complaint of a bird foot found in the baked product.
Lamb's Supreme Starz (Star-shaped Hash Brown Patties) are recalled due to contamination with foreign material.
Smoked Silver Salmon product, 6.5 oz. jars and cans, brand Smoked Alaska, is recalled because it has the potential to be contaminated with Clostridium botulinum.
Product contains undeclared sesame seeds.
Firm received a complaint of a bird foot found in the baked product.
Firm received a complaint of a bird foot found in the baked product.
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.
Lack of Assurance of Sterility
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
Subpotent Drug.
Lack of Assurance of Sterility
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
Sub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
